• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2019

View Archived Issues

Toughening up amyloid fibrils

Read More

New genetic alphabet doubles the fun

Read More

Cell Medica awarded grant for development of CAR-NK T-cell therapy

Read More

Correlation of immune characteristics with immune control and treatment efficacy in herpes labialis

Read More

Bayer presents novel adenosine A2B receptor antagonist with potential for lung fibrosis

Read More

Improved lymphocyte access via development of a lymphatic-targeted dosing system

Read More

Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury

Read More

Beactica, VIB and CD3 enter drug discovery alliance

Read More

Sarepta Therapeutics announces preliminary results from first cohort in phase I/II study of MYO-101

Read More

Foamix presents positive safety and efficacy data from phase III study of FMX-103

Read More

Double dose of suicide genes increases beta-cell safety, efficacy

Read More

Dual adenosine receptor A2A/A2B receptor antagonists described by Merck & Co.

Read More

C/EBPdelta identified as a therapeutic target for IVIG-resistant Kawasaki disease

Read More

Improved safety and efficacy of a second-generation diphtheria toxin-based fusion protein

Read More

CytomX Therapeutics gives program highlights for CX-072 and CX-2009

Read More

Eisai to support AAR Japan program to raise awareness of mycetoma in Sudan

Read More

Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors

Read More

B7-H3.CAR-Ts demonstrate promising efficacy and safety in preclinical cancer models

Read More

New PI3Kgmma and PI3Kdelta inhibitors discovered at Columbia University

Read More

Nodthera patents NLRP3 inflammasome inhibitors

Read More

First patient dosed ORIENT-32 study of Tyvyt plus IBI-305 in HCC

Read More

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery present AR antagonists

Read More

Miransertib shows promising therapeutic efficacy in children with Proteus syndrome

Read More

NIAID is recruiting participants in phase I study of VRC-FLUNPF099-00-VP influenza vaccine

Read More

Acurx presents first-in-human data for ACX-362E

Read More

Novavax's phase III Prepare study of ResVax misses primary objective

Read More

Horizon Pharma reports phase III OPTIC study data for teprotumumab

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 2, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Drug vials

    Industry could feel fallout of Pfizer vaccine scrutiny

    BioWorld
    In subpoenaing a former Pfizer Inc. official to appear before the U.S. House Judiciary Committee July 22, Judiciary Chair Jim Jordan, R-Ohio, signaled legislative...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe